Chiu, Yen-LingYen-LingChiuWEI-CHOU LINShu, Kai-HsiangKai-HsiangShuFang, Yi-WenYi-WenFangFAN-CHI CHANGChou, Yu-HsiangYu-HsiangChouWu, Ching-FangChing-FangWuWEN-CHIH CHIANGSHUEI-LIONG LINYUNG-MING CHENMING-SHIOU WU2021-08-232021-08-2320211664-3224https://scholars.lib.ntu.edu.tw/handle/123456789/579119Galactose-deficient IgA1 (Gd-IgA1) and alternative complement pathway activation are considered to be involved in the pathogenesis of IgA nephropathy (IgAN). Nevertheless, the relationships between alternative pathway activation and disease activity or Gd-IgA1 level remains unclear.enC5a; IgA nephropathy; complement; factor B; galactose-deficient IgA1[SDGs]SDG3alternative complement pathway C3 C5 convertase; barium; complement component C3; complement component C3c; complement component C5a; corticosteroid; creatinine; cyclophosphamide; cyclosporine; dipeptidyl carboxypeptidase inhibitor; gadolinium; galactose; hemoglobin A1c; immunoglobulin A; immunoglobulin A1; immunoglobulin enhancer binding protein; immunoglobulin G; complement; complement component C5a; galactose; immunoglobulin A; adult; aged; antibody titer; Article; autophagosome; chronic kidney failure; complement activation; complement alternative pathway; creatinine blood level; diabetes mellitus; disease activity; end stage renal disease; enzyme immunoassay; enzyme linked immunosorbent assay; estimated glomerular filtration rate; female; flow cytometry; fluorescence microscopy; follow up; Fontan procedure; gene expression; glomerulus filtration rate; human; human tissue; immunofluorescence; immunoglobulin A nephropathy; immunoglobulin blood level; immunohistochemistry; immunosuppressive treatment; kidney biopsy; kidney function; kidney transplantation; major clinical study; male; microalbuminuria; prospective study; protein expression; sclerosis; SLEDAI; case control study; focal glomerulosclerosis; genetics; immunoglobulin A nephropathy; immunology; metabolism; middle aged; Adult; Case-Control Studies; Complement C5a; Complement Pathway, Alternative; Complement System Proteins; Female; Follow-Up Studies; Galactose; Glomerulonephritis, IGA; Glomerulosclerosis, Focal Segmental; Humans; Immunoglobulin A; Male; Middle AgedAlternative Complement Pathway Is Activated and Associated with Galactose-Deficient IgA1 Antibody in IgA Nephropathy Patientsjournal article10.3389/fimmu.2021.638309341778892-s2.0-85109044427https://scholars.lib.ntu.edu.tw/handle/123456789/572322